AS 1269574

CAS No. 330981-72-1

AS 1269574( AS1269574 )

Catalog No. M24268 CAS No. 330981-72-1

AS 1269574 is a potent, orally available GPR119 agonist. AS1269574 has the potential for the research of type 2 diabetes.

Purity : >98% (HPLC)

COA Datasheet HNMR HPLC MSDS Handing Instructions
Size Price / USD Stock Quantity
2MG 37 In Stock
5MG 58 In Stock
10MG 98 In Stock
25MG 186 In Stock
50MG 295 In Stock
100MG 441 In Stock
500MG 981 In Stock
1G Get Quote In Stock

Biological Information

  • Product Name
    AS 1269574
  • Note
    Research use only, not for human use.
  • Brief Description
    AS 1269574 is a potent, orally available GPR119 agonist. AS1269574 has the potential for the research of type 2 diabetes.
  • Description
    AS 1269574 is a potent, orally available GPR119 agonist. AS1269574 has the potential for the research of type 2 diabetes.
  • In Vitro
    ——
  • In Vivo
    AS1269574 sgnificantly reduced the blood glucose AUC after 2 h (AUC0-2h) of administration. Animal Model:Eight-week-old ICR mice Dosage:100 mg/kg Administration:P.o.Result:Sgnificantly reduced the blood glucose AUC after 2 h (AUC0-2h) of administration. Similarly, plasma insulin AUC0-2h was significantly higher in the mice.
  • Synonyms
    AS1269574
  • Pathway
    Cell Cycle/DNA Damage
  • Target
    GPR
  • Recptor
    GPR119|TRPA1
  • Research Area
    ——
  • Indication
    ——

Chemical Information

  • CAS Number
    330981-72-1
  • Formula Weight
    308.18
  • Molecular Formula
    C13H14BrN3O
  • Purity
    >98% (HPLC)
  • Solubility
    DMSO:250 mg/mL (811.24 mM; Need ultrasonic)
  • SMILES
    CC1=CC(=NC(=N1)C2=CC=C(C=C2)Br)NCCO
  • Chemical Name
    ——

Shipping & Storage Information

  • Storage
    (-20℃)
  • Shipping
    With Ice Pack
  • Stability
    ≥ 2 years

Reference

1.Yoshida S, et al. Identification of a novel GPR119 agonist, AS1269574, with in vitro and in vivo glucose-stimulated insulin secretion. Biochem Biophys Res Commun. 2010;400(3):437-441.
molnova catalog
related products
  • Ogremorphin

    Ogremorphin (GPR68-IN-1) is a potent inhibitor of GPR68 with an EC50 of 170 nM, used in the study of autoimmune chronic inflammatory diseases .

  • CAY10595

    CAY10595 is an antagonist of the CRTh2 (DP2) receptor with a Ki of 10 nM.

  • Kuwanon H

    Kuwanon H is a specific antagonist for the gastrin-releasing peptide (GRP) -preferring receptor with Ki values of 290 nM and can be useful for studying the physiological and pathological role of GRP. Kuwanon H is a potent non-peptide bombesin receptor antagonist.